VREOF - Vireo Health International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2018-12-30
2017-12-30
2016-12-30
2015-12-30
Total Revenue
-
0
-
-
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
8,965
139
84
120
58
Total Operating Expenses
9,509
139
84
120
58
Operating Income or Loss
4,697
-139
-84
-120
-58
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-
-
12
-1
Income Before Tax
-2,586
-139
-84
-108
-59
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-5,443
-139
-84
-108
-59
Net Income
-5,443
-139
-84
-108
-59
Net Income available to common shareholders
-5,443
-139
-84
-108
-59
Reported EPS
Basic
-
-0.28
-0.15
-0.29
-0.18
Diluted
-
-0.28
-0.15
-0.29
-0.18
Weighted average shares outstanding
Basic
-
642
380
333
333
Diluted
-
642
380
333
333
EBITDA
-
-139
-84
-120
-58